The treatment of malignancy by hyperthermia - PubMed

Review

The treatment of malignancy by hyperthermia

C Christophi et al. Surg Oncol. 1998 Jul-Aug.

Abstract

The use of hyperthermia for the selective destruction of tumours may be applied by a whole body, surgical perfusion or interstitial techniques. The main determinant of selectivity is tumour blood flow. The effects of hyperthermia may be augmented by step-down heating, manipulating pH changes and sensitisation by chemotherapy or specific pharmacological agents.

Similar articles

• The present status of hyperthermia in Japan.

  Matsuda T. Matsuda T. Ann Acad Med Singap. 1996 May;25(3):420-4. Ann Acad Med Singap. 1996. PMID: 8876910 Review.

• [Present clinical status of hyperthermia associated with radiotherapy (author's transl)].

  Jaulerry C, Bataini JP, Brunin F, Gaboriaud G. Jaulerry C, et al. Bull Cancer. 1981;68(3):261-7. Bull Cancer. 1981. PMID: 7039730 Review. French.

• Hyperthermia in the treatment of cancer. Perspectives on its promise and its problems.

  Stewart JR, Gibbs FA Jr. Stewart JR, et al. Cancer. 1984 Dec 1;54(11 Suppl):2823-30. doi: 10.1002/1097-0142(19841201)54:2+<2823::aid-cncr2820541430>3.0.co;2-7. Cancer. 1984. PMID: 6388817 Review.

• Modification of human tumour and normal tissue pH during hyperthermic and normothermic antiblastic regional isolation perfusion for malignant melanoma: a pilot study.

  van de Merwe SA, van den Berg AP, Kroon BB, van den Berge AW, Klaase JM, van der Zee J. van de Merwe SA, et al. Int J Hyperthermia. 1993 Mar-Apr;9(2):205-17. doi: 10.3109/02656739309022535. Int J Hyperthermia. 1993. PMID: 8468505

• Technical aspects of hyperthermia.

  Turner PF, Schaefermeyer T. Turner PF, et al. Recent Results Cancer Res. 1988;107:76-86. doi: 10.1007/978-3-642-83260-4_10. Recent Results Cancer Res. 1988. PMID: 3287524 Review. No abstract available.

Cited by

• Image-guided percutaneous ablation therapies for local recurrences of thyroid tumors.

  Pacella CM, Papini E. Pacella CM, et al. J Endocrinol Invest. 2013 Jan;36(1):61-70. doi: 10.1007/BF03346744. J Endocrinol Invest. 2013. PMID: 23391859 Review.

• Magnetic nanoparticles in theranostics of malignant melanoma.

  Shevtsov M, Kaesler S, Posch C, Multhoff G, Biedermann T. Shevtsov M, et al. EJNMMI Res. 2021 Dec 14;11(1):127. doi: 10.1186/s13550-021-00868-6. EJNMMI Res. 2021. PMID: 34905138 Free PMC article. Review.

• Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment.

  Silva AC, Oliveira TR, Mamani JB, Malheiros SM, Malavolta L, Pavon LF, Sibov TT, Amaro E Jr, Tannús A, Vidoto EL, Martins MJ, Santos RS, Gamarra LF. Silva AC, et al. Int J Nanomedicine. 2011;6:591-603. doi: 10.2147/IJN.S14737. Epub 2011 Mar 25. Int J Nanomedicine. 2011. PMID: 21674016 Free PMC article. Review.

• Combining Bulk Temperature and Nanoheating Enables Advanced Magnetic Fluid Hyperthermia Efficacy on Pancreatic Tumor Cells.

  Engelmann UM, Roeth AA, Eberbeck D, Buhl EM, Neumann UP, Schmitz-Rode T, Slabu I. Engelmann UM, et al. Sci Rep. 2018 Sep 4;8(1):13210. doi: 10.1038/s41598-018-31553-9. Sci Rep. 2018. PMID: 30181576 Free PMC article.

• Temperature-dependent and time-dependent effects of hyperthermia mediated by dextran-coated La0.7Sr0.3MnO3: in vitro studies.

  Haghniaz R, Umrani RD, Paknikar KM. Haghniaz R, et al. Int J Nanomedicine. 2015 Feb 25;10:1609-23. doi: 10.2147/IJN.S78167. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25759583 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database